SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
Frequently asked questions
What sector does SANUWAVE Health Inc (SNWV) operate in?
SANUWAVE Health Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is SANUWAVE Health Inc (SNWV) current stock price?
As of the latest data, SANUWAVE Health Inc stock price is $5.07, with a previous close of $5.22. SANUWAVE Health Inc lost -$0.15 in the last trading session, representing a -2.87% loss.
What is SANUWAVE Health Inc (SNWV) current market capitalization?
SANUWAVE Health Inc market cap is approximately 43.61 million.
What is SANUWAVE Health Inc (SNWV) Earnings Per Share (EPS)?
The trailing EPS is $0.23, and the forward EPS is $0.37.
What is SANUWAVE Health Inc (SNWV) Price-to-Earnings (P/E) ratio?
SANUWAVE Health Inc current P/E ratio is 22.04, with a forward P/E of 13.7.
What is SANUWAVE Health Inc (SNWV) EBITDA?
SANUWAVE Health Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 193.00 thousand.
Does SANUWAVE Health Inc (SNWV) pay dividends?
No. SANUWAVE Health Inc does not pay a dividend.
When is SANUWAVE Health Inc (SNWV) next earnings report?
SANUWAVE Health Inc is expected to release its next earnings report on September 30, 2026.
What is SANUWAVE Health Inc (SNWV) beta (volatility) score?
SANUWAVE Health Inc has a beta of 1.416, suggesting it is more volatile than the market.
